Page last updated: 2024-10-20

porphobilinogen and Neuromuscular Diseases

porphobilinogen has been researched along with Neuromuscular Diseases in 1 studies

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research Excerpts

ExcerptRelevanceReference
"Urinary excretion of porphyrin precursors delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) and total porphyrins was measured during intoxication of rats with 2,4-dithiobiuret (DTB), a chemical which produces delayed-onset neuromuscular weakness, in an attempt to ascertain whether or not DTB poisoning in the rat would serve as an animal model of the neurologic symptoms of acute intermittent porphyria."3.67Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret. ( Atchison, WD; Peterson, RE, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atchison, WD1
Peterson, RE1

Other Studies

1 other study available for porphobilinogen and Neuromuscular Diseases

ArticleYear
Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Experimental neurology, 1984, Volume: 85, Issue:1

    Topics: Aminolevulinic Acid; Animals; Disease Models, Animal; Levulinic Acids; Male; Muscle Hypotonia; Neuro

1984